William Tzu‐Liang Chen

1.7k total citations
71 papers, 965 citations indexed

About

William Tzu‐Liang Chen is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William Tzu‐Liang Chen has authored 71 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 31 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William Tzu‐Liang Chen's work include Colorectal Cancer Surgical Treatments (31 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Colorectal and Anal Carcinomas (14 papers). William Tzu‐Liang Chen is often cited by papers focused on Colorectal Cancer Surgical Treatments (31 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Colorectal and Anal Carcinomas (14 papers). William Tzu‐Liang Chen collaborates with scholars based in Taiwan, China and Austria. William Tzu‐Liang Chen's co-authors include Tao‐Wei Ke, Shu‐Fen Chiang, K. S. Clifford Chao, Tsung-Wei Chen, Kevin Chih‐Yang Huang, Ying‐Shu You, Abe Fingerhut, Ji‐An Liang, Chen‐Yu Lin and Chih‐Yang Huang and has published in prestigious journals such as Nature Communications, Scientific Reports and Frontiers in Immunology.

In The Last Decade

William Tzu‐Liang Chen

67 papers receiving 963 citations

Peers

William Tzu‐Liang Chen
Kiyokazu Hiwatashi Japan
Kai Lee Yap United States
Shuai Ren China
Jianjun Han China
Federica Spadaccino Italy
Yifu He China
Min Feng China
Jianwei Lu China
Federica Rascio Italy
Xuequan Yao China
Kiyokazu Hiwatashi Japan
William Tzu‐Liang Chen
Citations per year, relative to William Tzu‐Liang Chen William Tzu‐Liang Chen (= 1×) peers Kiyokazu Hiwatashi

Countries citing papers authored by William Tzu‐Liang Chen

Since Specialization
Citations

This map shows the geographic impact of William Tzu‐Liang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Tzu‐Liang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Tzu‐Liang Chen more than expected).

Fields of papers citing papers by William Tzu‐Liang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Tzu‐Liang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Tzu‐Liang Chen. The network helps show where William Tzu‐Liang Chen may publish in the future.

Co-authorship network of co-authors of William Tzu‐Liang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of William Tzu‐Liang Chen. A scholar is included among the top collaborators of William Tzu‐Liang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Tzu‐Liang Chen. William Tzu‐Liang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ke, Tao‐Wei, Chia-Yi Chen, William Tzu‐Liang Chen, et al.. (2025). Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy. npj Vaccines. 10(1). 80–80. 2 indexed citations
2.
Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Shin‐Lei Peng, et al.. (2024). TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell Death and Disease. 15(1). 24–24. 25 indexed citations
3.
Ke, Tao‐Wei, et al.. (2024). Effect of autologous dendritic cell cytokine-induced killer on refractory metastatic colorectal cancer: a matched case–control comparative study. Frontiers in Immunology. 15. 1329615–1329615. 2 indexed citations
4.
Ke, Tao‐Wei, Shu‐Fen Chiang, Tsung-Wei Chen, et al.. (2024). Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma. Anticancer Research. 44(2). 787–796. 3 indexed citations
5.
Chang, Chia‐Lin, Kevin Chih‐Yang Huang, Tsung-Wei Chen, et al.. (2023). Impact of Pattern Recognition Receptors on the Prognosis of Chemotherapy-treated Rectal Cancer Patients. In Vivo. 37(4). 1552–1561.
6.
Shen, Ming‐Yin, et al.. (2023). Evaluation of the Prognostic Value of Low-Frequency KRAS Mutation Detection in Circulating Tumor DNA of Patients with Metastatic Colorectal Cancer. Journal of Personalized Medicine. 13(7). 1051–1051. 3 indexed citations
7.
Huang, Kevin Chih‐Yang, Tao‐Wei Ke, Jiayi Chen, et al.. (2023). Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Scientific Reports. 13(1). 19440–19440. 4 indexed citations
8.
Huang, Kevin Chih‐Yang, Hsin-Yu Chang, Shu‐Fen Chiang, et al.. (2022). A Novel Engineered AAV-Based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors. Cancer Immunology Research. 11(1). 123–136. 26 indexed citations
9.
Lee, Tsung‐Han, Tao‐Wei Ke, Yi‐Chang Chen, et al.. (2022). Peritoneal contamination and associated post-operative infectious complications after natural orifice specimen extraction for laparoscopic colorectal surgery. Surgical Endoscopy. 36(12). 8825–8833. 2 indexed citations
10.
Chen, Tsung-Wei, Shu‐Fen Chiang, William Tzu‐Liang Chen, et al.. (2022). Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1. Cancer Letters. 543. 215795–215795. 38 indexed citations
11.
Yeh, Kun‐Huei, Tsai‐Sheng Yang, Tzu‐Chi Hsu, et al.. (2021). Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan. Journal of the Formosan Medical Association. 120(11). 2023–2031. 9 indexed citations
12.
Yen, Yu‐Ting, May Chien, Pei‐Yi Wu, et al.. (2021). Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response. Nature Communications. 12(1). 7297–7297. 38 indexed citations
13.
Shen, Ming‐Yin & William Tzu‐Liang Chen. (2020). Natural Orifice Specimen Extraction (NOSE) with SingleStapling Anastomosis for Left Colon Cancer. Daehan nae'si'gyeong bog'gang'gyeong oe'gwa haghoeji/Journal of minimally invasive surgery. 23(4). 201–203. 2 indexed citations
14.
Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Tsung-Wei Chen, et al.. (2020). Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy. Scientific Reports. 10(1). 22330–22330. 16 indexed citations
15.
Chen, Tsung-Wei, Kevin Chih‐Yang Huang, Shu‐Fen Chiang, et al.. (2019). Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy. Journal of Cancer Research and Clinical Oncology. 145(4). 1043–1053. 45 indexed citations
16.
Yang, Horng-Ren, et al.. (2018). Laparoscopic Liver Resection: Experience of 436 Cases in One Center. Journal of Gastrointestinal Surgery. 23(10). 1949–1956. 13 indexed citations
17.
Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Tao‐Wei Ke, et al.. (2018). Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer. Scientific Reports. 8(1). 15658–15658. 52 indexed citations
18.
19.
20.
Ke, Tao‐Wei, et al.. (2008). Laparoscopic Abdominoperineal Resection for Low Rectal Adenocarcinoma. 19(3). 63–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyokazu Hiwatashi Breakdown of academic impact, for papers by Kai Lee Yap Breakdown of academic impact, for papers by Shuai Ren Breakdown of academic impact, for papers by Jianjun Han Breakdown of academic impact, for papers by Federica Spadaccino Breakdown of academic impact, for papers by Yifu He Breakdown of academic impact, for papers by Min Feng Breakdown of academic impact, for papers by Jianwei Lu Breakdown of academic impact, for papers by Federica Rascio Breakdown of academic impact, for papers by Xuequan Yao
Rankless by CCL
2026